Rossi, Giulio

Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec 2005 - 8774-85 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.2005.02.8233 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Carcinoma, Large Cell--drug therapy
Carcinoma, Neuroendocrine--drug therapy
Carcinoma, Small Cell--drug therapy
Cisplatin--administration & dosage
DNA Mutational Analysis
Deoxycytidine--administration & dosage
Female
Follow-Up Studies
Humans
Immunohistochemistry
Lung Neoplasms--drug therapy
Male
Middle Aged
Multivariate Analysis
Neoplasm Staging
Paclitaxel--administration & dosage
Polymerase Chain Reaction
Proto-Oncogene Proteins c-kit--biosynthesis
Proto-Oncogene Proteins c-met--biosynthesis
Receptor Protein-Tyrosine Kinases--biosynthesis
Receptor, Platelet-Derived Growth Factor alpha--biosynthesis
Receptor, Platelet-Derived Growth Factor beta--biosynthesis
Survival Analysis
Survival Rate
Treatment Outcome
Gemcitabine